Ugarov V I, Zuev A V, Rebentish B A, Kriviskiĭ A S
Mol Gen Mikrobiol Virusol. 1985 Aug(8):21-6.
The technique of localized in vitro mutagenesis in the cohesive ends of plasmid pBR322 DNA has been elaborated (separately for BamHI and HindIII sites). Plasmid DNA digested by restriction endonucleases has been treated with sodium bisulphite deaminating cytosine to form uracil in single stranded DNA (cohesive ends of the plasmid). The mutagenized plasmid DNA, free of mutagen, has been treated with bacteriophage T4 ligase. E. coli C600 cells were subsequently transformed by the ligated DNA preparation. The clones having tetracycline gene mutagenized represented 4.0-11.1% and 1.2-3.1% among HindIII and BamHI mutants, respectively, selected as TcR----TcS transformants. Selection of mutagenized DNA by the second endonuclease restriction has increased the mutant yields up to 55.6-78.0% and 10.0-75.4%, respectively. The yield of TcS mutations in the control DNA treated at all stages of experiment, except for mutagen treatment, has reached 0.06% and 0.2%, respectively.
已详细阐述了在质粒pBR322 DNA粘性末端进行局部体外诱变的技术(分别针对BamHI和HindIII位点)。用限制性内切酶消化的质粒DNA已用亚硫酸氢钠处理,使胞嘧啶脱氨基,在单链DNA(质粒的粘性末端)中形成尿嘧啶。已用噬菌体T4连接酶处理不含诱变剂的诱变质粒DNA。随后用连接的DNA制剂转化大肠杆菌C600细胞。在作为TcR----TcS转化体选择的HindIII和BamHI突变体中,具有诱变四环素基因的克隆分别占4.0 - 11.1%和1.2 - 3.1%。通过第二种内切酶限制选择诱变DNA分别将突变体产量提高到55.6 - 78.0%和10.0 - 75.4%。在除诱变处理外的实验所有阶段均进行处理的对照DNA中,TcS突变的产量分别达到0.06%和0.2%。